Details for New Drug Application (NDA): 020701

✉ Email this page to a colleague

NDA 020701 describes CRINONE, which is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. Additional details are available on the CRINONE profile page.

The generic ingredient in CRINONE is progesterone. There are fifty-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the progesterone profile page.

Summary for 020701

Tradename:	CRINONE
Applicant:	Allergan
Ingredient:	progesterone
Patents:	0

Pharmacology for NDA: 020701

Medical Subject Heading (MeSH) Categories for 020701

Progestins

Suppliers and Packaging for NDA: 020701

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CRINONE	progesterone	GEL;VAGINAL	020701	NDA	Allergan, Inc.	0023-6150	0023-6150-04	6 APPLICATOR in 1 CARTON (0023-6150-04) / 1.125 g in 1 APPLICATOR
CRINONE	progesterone	GEL;VAGINAL	020701	NDA	Allergan, Inc.	0023-6151	0023-6151-08	15 APPLICATOR in 1 CARTON (0023-6151-08) / 1.125 g in 1 APPLICATOR

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	GEL;VAGINAL			Strength	4%
Approval Date:	Jul 31, 1997	TE:		RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	GEL;VAGINAL			Strength	8%
Approval Date:	Jul 31, 1997	TE:		RLD:	Yes

Expired US Patents for NDA 020701

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Allergan	CRINONE	progesterone	GEL;VAGINAL	020701-002	Jul 31, 1997	⤷ Sign Up	⤷ Sign Up
Allergan	CRINONE	progesterone	GEL;VAGINAL	020701-001	Jul 31, 1997	⤷ Sign Up	⤷ Sign Up
Allergan	CRINONE	progesterone	GEL;VAGINAL	020701-002	Jul 31, 1997	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.